Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Deanna Church, Robert Nussbaum, Robert Green, More

Premium

Personalis has hired Deanna Church to the position of senior director of genomics and content. Church joined Personalis from the National Institutes of Health's National Center for Biotechnology Information, where she was a staff scientist for 12 years. She holds a PhD from the University of California, Irvine and a BA from the University of Virginia.

Personalis has also appointed Robert Nussbaum to its clinical and scientific advisory board. Nussbaum is a professor of medicine and chief of the division of genomic medicine at the University of California, San Francisco.


Bina Technologies, which is developing clinical analysis tools for whole-genome sequencing, has appointed Robert Green, Shashikant Kulkarni, Rong Chen, and Mark Gerstein to its scientific advisory board.

Green is an associate professor of medicine in the Division of Genetics at Brigham and Women's Hospital and Harvard Medical School. He is also associate director for research at the Partners HealthCare Center for Personalized Genetic Medicine.

Kulkarni is director of cytogenomics and molecular pathology, director of the Clinical Genomics Research Unit, and an associate professor of pediatrics, genetics, and pathology at the Washington University School of Medicine.

Chen is director of clinical genome informatics at the Icahn Institute of Genetics and Multiscale Biology.

Gerstein is the Albert Williams Professor of Biomedical Informatics, Molecular Biophysics & Biochemistry, and Computer Science at Yale University.

In addition, Bina has hired Janet Lankard as vice president of sales and Gianfranco de Feo as vice president of marketing.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.